Asian Pacific Journal of Cancer Prevention

Asian Pacific Journal of Cancer Prevention (아시아태평양암예방학회)
권호 표지
DOI QR코드

DOI QR Code

Metabolic Syndrome and Colorectal Cancer: A Cross-Sectional Survey

  • Forootan, Mojgan (Gastroenterology and Liver Diseases Research Center, Shaheed Beheshti University of Medical Sciences) ;
  • Tabatabaeefar, Morteza (Imam Hossein Hospital, Shaheed Beheshti University of Medical Sciences) ;
  • Yahyaei, Mansooreh (Gastroenterology and Liver Diseases Research Center, Shaheed Beheshti University of Medical Sciences) ;
  • Maghsoodi, Nakisa (Gastroenterology and Liver Diseases Research Center, Shaheed Beheshti University of Medical Sciences)
  • Published : 2012.10.31
Download PDF
⟨ Previous Next ⟩

Abstract

Introduction: There is epidemiological evidence indicating that the metabolic syndrome increases the risk of colorectal cancer. Since there is little information about this issue in Iran, the present study was conducted to evaluate prevalence of metabolic syndrome and its components in patients with colorectal cancer. Material and Methods: This cross-sectional survey involved 200 patients with a new diagnosis of colorectal cancer. Demographic information of patients was collected through the interview with them. Components of metabolic syndrome including fasting glucose serum, triglyceride, high density lipoprotein, blood pressure and waist circumference were measured for all of the patients. Results: A total of 72 colorectal cancer patients (36%) met metabolic syndrome criteria with rates of 76% for women and 24% for men. BMI in metabolic syndrome patients was higher than other colorectal cancer patients. Disease history including hypertension, diabetes and cardiovascular disease was most frequent in metabolic syndrome patients. Pathological characteristics of colorectal cancer were not significantly associated with the disease. Conclusion: The findings of present study indicated that the prevalence of metabolic syndrome in CRC patients is relatively high. Therefore, further analytical and multi centric studies are needed to better understand the role of metabolic syndrome in development of CRC in Iran. If this association is confirmed in future studies, metabolic syndrome patients should be considered in CRC screening programs.

Keywords

References

  1. Ahmed RL, Schmitz KH, Anderson KE, et al (2006). The metabolic syndrome and risk of incident colorectal cancer. Cancer, 107, 28-36. https://doi.org/10.1002/cncr.21950
  2. Ayatollahi SM, Ghoreshizadeh Z (2010). Prevalence of obesity and overweight among adults in Iran. Obes Rev, 11, 335-7. https://doi.org/10.1111/j.1467-789X.2010.00725.x
  3. Cameron AJ, Shaw JE, Zimmet PZ (2004). The metabolic syndrome: prevalence in worldwide populations. Endocrinol Metab Clin North Am, 33, 351-75. https://doi.org/10.1016/j.ecl.2004.03.005
  4. Chiu HM, Lin JT, Shun CT, et al (2007). Association of metabolic syndrome with proximal and synchronous colorectal neoplasm. Clin Gastroenterol Hepatol, 5, 221-9. https://doi.org/10.1016/j.cgh.2006.06.022
  5. Chung YW, Han DS, Park YK, et al (2006). Association of obesity, serum glucose and lipids with the risk of advanced colorectal adenoma and cancer: a case-control study in Korea. Dig Liver Dis, 38, 668-72. https://doi.org/10.1016/j.dld.2006.05.014
  6. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III) (2001). JAMA, ?, PAGE?-?.
  7. Frezza EE, Wachtel MS, Chiriva-Internati M (2006). Influence of obesity on the risk of developing colon cancer. Gut, 55, 285-91. https://doi.org/10.1136/gut.2005.073163
  8. Giovannucci E (2003). Nutrition, insulin, insulin-like growth factors and cancer. Horm Metab Res, 35, 694-704. https://doi.org/10.1055/s-2004-814147
  9. Kim JH, Lim YJ, Kim YH, et al (2007). Is metabolic syndrome a risk factor for colorectal adenoma? Cancer Epidemiol Biomarkers Prev, 16, 1543-6. https://doi.org/10.1158/1055-9965.EPI-07-0199
  10. Morita T, Tabata S, Mineshita M, et al (2005). The metabolic syndrome is associated with increased risk of colorectal adenoma development: the self-defense forces health study. Asian Pac J Cancer Prev, 6, 485-9.
  11. Pais R, Silaghi H, Silaghi AC, et al (2009). Metabolic syndrome and risk of subsequent colorectal cancer. World J Gastroenterol, 15, 5141-8. https://doi.org/10.3748/wjg.15.5141
  12. Pelucchi C, Negri E, Talamini R, et al (2010). Metabolic syndrome is associated with colorectal cancer in men. Eur J Cancer, 46, 1866-72. https://doi.org/10.1016/j.ejca.2010.03.010
  13. Rigo JC, Vieira JL, Dalacorte RR, et al (2009). Prevalence of metabolic syndrome in an elderly community: comparison between three diagnostic methods. Arq Bras Cardiol, 93, 85-91. https://doi.org/10.1590/S0066-782X2009000800004
  14. Safaee A, Fatemi R, Pourhoseingholi M, et al (2009). Positive Association between diabetes mellitus and risk of colorectal cancer. Iran J Cancer Prev, 2, 189-93.
  15. Schoen RE, Tangen CM, Kuller LH, et al (1999). Increased blood glucose and insulin, body size, and incident colorectal cancer. J Natl Cancer Inst, 91, 1147-54. https://doi.org/10.1093/jnci/91.13.1147
  16. Siddiqui AA (2011). Metabolic syndrome and its association with colorectal cancer: a review. Am J Med Sci, 341, 227-31. https://doi.org/10.1097/MAJ.0b013e3181df9055
  17. Slattery ML, Murtaugh M, Caan B, et al (2004). Associations between BMI, energy intake, energy expenditure, VDR genotype and colon and rectal cancers (United States). Cancer Causes Control, 15, 863-72. https://doi.org/10.1007/s10552-004-1048-6
  18. Sturmer T, Buring JE, Lee IM, et al (2006). Metabolic abnormalities and risk for colorectal cancer in the physicians' health study. Cancer Epidemiol Biomarkers Prev, 15, 2391-7. https://doi.org/10.1158/1055-9965.EPI-06-0391
  19. Tsilidis KK, Brancati FL, Pollak MN, et al (2010). Metabolic syndrome components and colorectal adenoma in the CLUE II cohort. Cancer Causes Control, 21, 1-10. https://doi.org/10.1007/s10552-009-9428-6
  20. Wang YY, Lin SY, Lai WA, et al (2005). Association between adenomas of rectosigmoid colon and metabolic syndrome features in a Chinese population. J Gastroenterol Hepatol, 20, 1410-5. https://doi.org/10.1111/j.1440-1746.2005.03971.x

Cited by

  1. Prevalence of the Metabolic Syndrome and Associated Factors in Korean Cancer Survivors vol.14, pp.3, 2013, https://doi.org/10.7314/APJCP.2013.14.3.1773
  2. Clinicopathological Features of Colon Adenocarcinoma in Qazvin, Iran: A 16 Year Study vol.15, pp.2, 2014, https://doi.org/10.7314/APJCP.2014.15.2.951
  3. An Overview of Clinical and Pathological Characteristics and Survival Rate of Colorectal Cancer in Iran vol.2, pp.1, 2014, https://doi.org/10.17795/acr-17264
  4. Diabetes-induced mechanophysiological changes in the small intestine and colon vol.8, pp.6, 2017, https://doi.org/10.4239/wjd.v8.i6.249
  5. Hypertension and Subsequent Genitourinary and Gynecologic Cancers Risk vol.94, pp.16, 2015, https://doi.org/10.1097/MD.0000000000000753
  6. Active lifestyle patterns reduce the risk of colorectal cancer in the Mecca region, Saudi Arabia pp.0959-8278, 2017, https://doi.org/10.1097/CEJ.0000000000000361